HimanshuUpadhyayaMD

PubMed

• 1 citations
  Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2...
  Himanshu P Upadhyaya, Jenny Y Chien, Amanda J Long, Martin S Bohm, Nicole L Kallewaard, Lisa F Macpherson, Dipak R Patel, Matthew M Hufford, Constance J Krull, Jocelyn...> ;Infectious Diseases and Therapy. 2023 Jul 1
• 5 citations
  Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic.
  Russell M Nichols, Carmen Deveau, Himanshu Upadhyaya> ;The Lancet. Infectious Diseases. 2022 Nov 1
• 24 citations
  Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
  Krista F. Huybrechts, Brian T. Bateman, Ajinkya Pawar, Lily G. Bessette, Helen Mogun, Raisa Levin, Hu Li, Stephen P. Motsko, Maria Fernanda Scantamburlo Fernandes, Him...> ;BMJ. 2020 Feb 19
• 4 citations
  Executive Functioning Outcomes Over 6 Months of Atomoxetine for Adults With ADHD: Relationship to Maintenance of Response and Relapse Over the Subsequent 6 Months Afte...
  Lenard A. Adler, Mary V. Solanto, Rodrigo Escobar, Sarah Lipsius, Himanshu P. Upadhyaya> ;Journal of Attention Disorders. 2020 Feb 1
• 18 citations
  Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
  Himanshu P. Upadhyaya, Lesley M. Arnold, Karla Alaka, Meihua Qiao, David A. Williams, Renata Mehta> ;Pediatric Rheumatology Online Journal. 2019 May 28
• 4 citations
  What Is a Clinically Relevant Improvement in Quality of Life in Adults With ADHD
  Yoko Tanaka, Meryl Brod, Jeannine R. Lane, Himanshu P. Upadhyaya> ;Journal of Attention Disorders. 2019 Jan 1
• Evaluation of dystonia in children and adolescents treated with atomoxetine within the Truven MarketScan database: a retrospective cohort study.
  Kristin J. Meyers, Himanshu P. Upadhyaya, Robert Goodloe, Ludmila Kryzhanovskaya, Marie A Liles-Burden, N Kellier-Steele, Michele Mancini> ;Expert Opinion on Drug Safety. 2018 Apr 13
• 12 citations
  Postinjection delirium/sedation syndrome in patients with schizophrenia receiving olanzapine long-acting injection: results from a large observational study
  Kristin J. Meyers, Himanshu P. Upadhyaya, John Landry, Rashna Chhabra-Khanna, Deborah M. Falk, Balasubramanya Seetharama Rao, Meghan E. Jones> ;Bjpsych Open. 2017 Jul 1
• Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term t...
  Johannes Thome, Ralf W. Dittmann, Laurence L Greenhill, Sarah Lipsius, Yoko Tanaka, Chris J Bushe, Rodrigo Escobar, Alexandra N. Heinloth, Himanshu P. Upadhyaya> ;Attention Deficit and Hyperactivity Disorders. 2017 May 5
• 22 citations
  A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.
  David B. Clemow, Chris J Bushe, Michele Mancini, Michael H. Ossipov, Himanshu P. Upadhyaya> ;Neuropsychiatric Disease and Treatment. 2017 Feb 3
• 1 citations
  Assessment of effects of atomoxetine in adult patients with ADHD: consistency among three geographic regions in a response maintenance study
  Yoko Tanaka, Rodrigo Escobar, Himanshu P. Upadhyaya> ;Attention Deficit and Hyperactivity Disorders. 2017 Jan 6
• 16 citations
  The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Resea...
  Victoria A Reed, Jan K Buitelaar, Ernie Anand, Kathleen Ann Day, Tamás Treuer, Himanshu P Upadhyaya, David R Coghill, Ludmila A Kryzhanovskaya, Nicola C Savill> ;CNS Drugs. 2016 Jul 1
• 20 citations
  Differences in maintenance of response upon discontinuation across medication treatments in attention-deficit/hyperactivity disorder.
  Jan K. Buitelaar, Philip Asherson, Cesar Soutullo, Michael Colla, David H. Adams, Yoko Tanaka, Virginia S. Haynes, Rodrigo Escobar, Himanshu P. Upadhyaya> ;European Neuropsychopharmacology. 2015 Oct 1
• 16 citations
  CYP2D6 predicted metabolizer status and safety in adult patients with attention-deficit hyperactivity disorder participating in a large placebo-controlled atomoxetine ...
  Bonnie Fijal, Yingying Guo, Si G. Li, Jonna Ahl, Taro Goto, Yoko Tanaka, Laura Nisenbaum, Himanshu P. Upadhyaya> ;Journal of Clinical Pharmacology. 2015 Oct 1
• 7 citations
  Time-to-onset and -resolution of adverse events before/after atomoxetine discontinuation in adult patients with ADHD.
  Himanshu P. Upadhyaya, Yoko Tanaka, Sarah Lipsius, Ludmila Kryzhanovskaya, Jeannine R. Lane, Rodrigo Escobar, Paula T. Trzepacz, Albert J. Allen> ;Postgraduate Medicine. 2015 Aug 31
• 10 citations
  Menstrual Cycle Phase Effects in the Gender Dimorphic Stress Cue Reactivity of Smokers
  Michael E. Saladin, Jennifer M. Wray, Matthew J. Carpenter, Erin A. McClure, Steven D. LaRowe, Himanshu P. Upadhyaya, Kevin M. Gray> ;Nicotine & Tobacco Research. 2015 May 1
• The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of cli...
  Savill NC, Buitelaar JK, Anand E, Day KA, Treuer T, Upadhyaya HP, Coghill D> ;CNS Drugs. 2015-02-01
• 16 citations
  Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale in European patients: comparison with patients from the USA
  Meryl Brod, Lenard A. Adler, Sarah Lipsius, Yoko Tanaka, Alexandra N. Heinloth, Himanshu P. Upadhyaya> ;Attention Deficit and Hyperactivity Disorders. 2015 Jan 7
• 16 citations
  Safety and tolerability of atomoxetine in treatment of attention deficit hyperactivity disorder in adult patients: An integrated analysis of 15 clinical trials
  A. Camporeale, Vibeke Porsdal, Katrien De Bruyckere, Yoko Tanaka, Himanshu P. Upadhyaya, Claudia Deix, Walter Deberdt> ;Journal of Psychopharmacology. 2015 Jan 1
• 10 citations
  Efficacy and Safety Extrapolation Analyses for Atomoxetine in Young Children with Attention-Deficit/Hyperactivity Disorder.
  Himanshu P. Upadhyaya, Christopher J. Kratochvil, Jaswinder K. Ghuman, A. Camporeale, Sarah Lipsius, Deborah N. D'Souza, Yoko Tanaka> ;Journal of Child and Adolescent Psychopharmacology. 2014 Sep 29
• 19 citations
  Executive function in adults with attention-deficit/hyperactivity disorder during treatment with atomoxetine in a randomized, placebo-controlled, withdrawal study.
  Lenard A. Adler, Yoko Tanaka, David A. Williams, Paula T. Trzepacz, Taro Goto, Albert John Allen, Rodrigo Escobar, Himanshu P. Upadhyaya> ;Journal of Clinical Psychopharmacology. 2014 Aug 1
• 36 citations
  Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials
  Philip Asherson, Chris J Bushe, Keith Saylor, Yoko Tanaka, Walter Deberdt, Himanshu P. Upadhyaya> ;Journal of Psychopharmacology. 2014 Jul 17
• 148 citations
  Underdiagnosis of Attention-Deficit/Hyperactivity Disorder in Adult Patients: A Review of the Literature
  Ylva Ginsberg, Javier Quintero, Ernie Anand, Marta Casillas, Himanshu P. Upadhyaya> ;The Primary Care Companion for CNS Disorders. 2014 Jun 15
• 33 citations
  Craving, Cue Reactivity, and Stimulus Control Among Early-Stage Young Smokers: Effects of Smoking Intensity and Gender
  Matthew J. Carpenter, Michael E. Saladin, Steven D. LaRowe, Erin A. McClure, Susan J. Simonian, Himanshu P. Upadhyaya, Kevin M. Gray> ;Nicotine & Tobacco Research. 2014 Feb 1
• 3 citations
  Validity of conners' adult attention-deficit/hyperactivity disorder rating Scale-investigator rated: screening version in patients from within and outside of Europe.
  J.J. Sandra Kooij, C. Keith Conners, Taro Goto, Yoko Tanaka, David R. Williams, Albert J. Allen, Alexandra N. Heinloth, Himanshu P. Upadhyaya> ;Psychiatry Research. 2013 Jun 30
• Join now to see all